 | Up a level |
2016
Knops, E., Kalaghatgi, P., Neumann-Fraune, M., Heger, E., Schuelter, E., Lengauer, T., Keitel, V., Goeser, T., Schuebel, N., von Hahn, T., Peuser, I., Qurishi, N., Roemer, K., Scholten, S., Daeumer, M., zur Wiesch, J. S., Baumgarten, A., Obermeier, M., Walter, H., Kaiser, R. and Sierra, S. (2016). HEPATITIS C VIRUS SCREENING PROJECT OF PATIENTS ON CURRENT ANTI-HCV THERAPY. J. Hepatol., 64. S. S402 - 1. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1600-0641
2014
De Luca, A., Flandre, P., Castagna, A., Ceccherini-Silberstein, F., Cozzi-Lepri, A., Churchill, D., De Wit, S., Dunn, D., Fuchs, W., Garcia, F., Guenthard, H., Imaz, A., Kordossis, T., Mussini, C., Obel, N., Roca, B., Santoro, M. M., Schuelter, E., Torti, C., van Sighem, A., Wensing, A. M., Wittkop, L., Zangerle, R., Zazzi, M. and Descamps, D. (2014). Improved weighted darunavir genotypic mutation score predicting treatment response for HIV-1 subtype B and non-B infected patients receiving darunavir in a salvage regimen. Antivir. Ther., 19. S. A142 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Dirks, M., Pfeifer, N., Schuelter, E., Esser, S., Faetkenheuer, G., Jenssen, B., Kaiser, R. and Verheyen, J. (2014). Insertions and deletions in p6-gag correlate with the predicted cellular tropism of HIV-1 V3 sequences. Antivir. Ther., 19. S. A116 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Schuelter, E., Kaiser, R., Zazzi, M., Soennerborg, A., Camacho, R. and Verheyen, J. (2014). Time on drug analysis based on real life data. Antivir. Ther., 19. S. A133 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
2012
Schuelter, E., Luebke, N., Jensen, B., Zazzi, M., Sonnerborg, A., Lengauer, T., Incardona, F., Camacho, R., Schmit, J., Clotet, B., Kaiser, R. and Pironti, A. (2012). Etravirine in protease inhibitor-free antiretroviral combination therapies. J. Int. AIDS Soc., 15. S. 155 - 157. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652